Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

Clinical trial NCT00132119 · COMPLETED

Trial details

NCT number: NCT00132119
Sponsor: Somaxon Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pathological Gambling

Start date: 2005-08-01
Primary completion: 2006-08-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.